Objective To observe the variation of immune functions in cancer patients when using CD3 monoclonal antibody activating cells(CD3AK) during chemotherapy or radiotherapy and intervals.

• 目的观察恶性肿瘤患者在化疗/放疗期间或间歇期辅以CD3AK细胞治疗前后免疫功能变化。